Replies to post #38368 on 22nd Century Group Inc (XXII)

[biotech2]

correct, BUT that's the limitation of technical analysis. What happens when you are waiting on the sidelines to fill a position and a clinical trial result or favorable FDA ruling comes along and BOOM, the stock gaps up by 200 %. IT HAPPENS ALL THE TIME in biotech land... SO, IMO, technicals are for more reliable stocks lke google, facebook,etc.

[Justfactsmam]

..yep... but the news has to be compelling...i.e. (IMHO) some signs of revenue generation that is measurable or will "force" BT to adopt VLN tobacco produced by XXII.

Investors seem to be tiring of nebulous "big picture" news...not tied to factual FDA "mandated rules" addressing "burn" or Big Tobacco doing a revenue deal...

...the rest IMHO...is positive fluff without FDA forcing use or BT adopting use of XXII technology.


Hemp/MJ...another long road ( a year, plus? ) before revenue is generated from XXII technology.

[esad1]

Wait until the 50 week goes through the 200 week...getting closer..